EDBI Pte Ltd - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 125 filers reported holding KEROS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
EDBI Pte Ltd ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$322,147
-20.7%
10,1050.0%0.35%
+6.4%
Q2 2023$406,019
-5.9%
10,1050.0%0.33%
-32.1%
Q1 2023$431,484
-11.1%
10,1050.0%0.48%
-21.8%
Q4 2022$485,242
+27.7%
10,1050.0%0.62%
+54.5%
Q3 2022$380,000
+36.2%
10,1050.0%0.40%
+54.4%
Q2 2022$279,000
-49.3%
10,1050.0%0.26%
-29.2%
Q1 2022$550,000
-6.9%
10,1050.0%0.37%
+14.0%
Q4 2021$591,00010,1050.32%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 407,633$12,995,3405.15%
Opaleye Management Inc. 360,400$11,489,5523.74%
Parkman Healthcare Partners LLC 298,475$9,515,3831.74%
BRAIDWELL LP 1,357,309$43,271,0111.37%
First Light Asset Management, LLC 421,438$13,435,4431.28%
Orbimed Advisors 1,514,734$48,289,7201.03%
Yiheng Capital Management, L.P. 554,151$17,666,3340.90%
Nantahala Capital Management 328,781$10,481,5380.90%
DAFNA Capital Management LLC 65,961$2,102,8370.65%
EDBI Pte Ltd 10,105$322,1470.35%
View complete list of KEROS THERAPEUTICS INC shareholders